|
A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
RECRUITINGPhase 2/3Sponsored by Mayo Clinic
Actively Recruiting
PhasePhase 2/3
SponsorMayo Clinic
Started2023-04-19
Est. completion2026-04
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05357690
Summary
The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.
Eligibility
Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria: * Patient presenting for cardiac surgery at the Mayo Clinic in Rochester, Minnesota. * Patients scheduled to undergo mitral or aortic valve surgery with or without coronary artery bypass grafting. Exclusion Criteria: * Patients with a history of permanent atrial fibrillation, left or right ventricular assist device implantation or explantation. * Patients with procedures not requiring cardiopulmonary bypass. * Patients with procedures requiring deep hypothermic circulatory arrest. * Patients with active infection or sepsis. * Pre-operative immunosuppressive medication use (including steroid use). * Pre-operative anti-arrhythmic medication use (aside from beta-blockers). * Patients with Immunodeficiency syndrome. * Patients with known neurologic disorder. * Patients requiring left internal jugular central line placement. * Performance of Maze procedures or left atrial appendage ligation procedures will not exclude patients from potential enrollment as atrial fibrillation still occurs postoperatively while the scarring from the Maze procedure forms.
Conditions2
Atrial FibrillationHeart Disease
Interventions1
Locations1 site
Mayo Clinic in Rochester
Find trials near these locations
Related trials
- Serratus Posterior Superior Plane Block in Minimally Invasive Cardiac Surgery — Kartal Kosuyolu High Speciality Training and Research Hospital
- Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery — Pacira Pharmaceuticals, Inc
- Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy — Masonic Cancer Center, University of Minnesota
- Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control — Memorial Sloan Kettering Cancer Center
- Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block — Duke University
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2/3
SponsorMayo Clinic
Started2023-04-19
Est. completion2026-04
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05357690